Literature DB >> 19152138

Imaging diabetes mellitus with coronary computed tomography angiography, cardiovascular magnetic resonance, and positron emission tomography.

Maleah Grover-McKay1.   

Abstract

The prevalence and medical expense associated with diabetes mellitus continue to increase. Using the diagnostic imaging techniques of coronary computed tomography angiography, cardiovascular magnetic resonance, and positron emission tomography, it may be possible to make earlier, non-invasive diagnoses of the type and extent of disease, thereby preventing or delaying some morbidity and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19152138     DOI: 10.1007/s12350-008-9038-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

1.  Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes.

Authors:  A J H A Scholte; J D Schuijf; A V Kharagjitsingh; J W Jukema; G Pundziute; E E van der Wall; J J Bax
Journal:  Heart       Date:  2007-07-23       Impact factor: 5.994

2.  Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control.

Authors:  Jina Chung; Paul Abraszewski; Xin Yu; Wei Liu; Andrew J Krainik; Marvin Ashford; Shelton D Caruthers; Janet B McGill; Samuel A Wickline
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

3.  Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy.

Authors:  Won Yong Kim; Anne Sofie Astrup; Matthias Stuber; Lise Tarnow; Erling Falk; René M Botnar; Cheryl Simonsen; Lotte Pietraszek; Peter R Hansen; Warren J Manning; Niels T Andersen; Hans-Henrik Parving
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.

Authors:  Pilar Herrero; Linda R Peterson; Janet B McGill; Stanley Matthew; Donna Lesniak; Carmen Dence; Robert J Gropler
Journal:  J Am Coll Cardiol       Date:  2006-01-18       Impact factor: 24.094

6.  Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction.

Authors:  Carissa G Fonseca; Ajith M Dissanayake; Robert N Doughty; Gillian A Whalley; Greg D Gamble; Brett R Cowan; Christopher J Occleshaw; Alistair A Young
Journal:  Am J Cardiol       Date:  2004-12-01       Impact factor: 2.778

7.  Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease.

Authors:  Jörg Hausleiter; Tanja Meyer; Martin Hadamitzky; Adnan Kastrati; Stefan Martinoff; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2006-06-22       Impact factor: 24.094

8.  Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.

Authors:  Linda R Peterson; Pilar Herrero; Janet McGill; Kenneth B Schechtman; Zulfia Kisrieva-Ware; Donna Lesniak; Robert J Gropler
Journal:  Diabetes       Date:  2007-10-03       Impact factor: 9.461

9.  Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction.

Authors:  Raymond Y Kwong; Hamid Sattar; Henry Wu; Gabriel Vorobiof; Vijay Gandla; Kevin Steel; Samuel Siu; Kenneth A Brown
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

10.  Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.

Authors:  Michaela Scheuermann-Freestone; Per L Madsen; David Manners; Andrew M Blamire; Robin E Buckingham; Peter Styles; George K Radda; Stefan Neubauer; Kieran Clarke
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.